Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy
Leukemia & Lymphoma | May 9, 2017 | Volume: 58 | Issue: 11 | Pages: 2588-2597
10.1080/10428194.2017.1312384
| PMID 28482728